Related Experiment Video

Updated: Jun 6, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.2K

KIF18A inhibition: the next big player in the search for cancer therapeutics

Ain Syafiza Mohd Amin1, Sarah Eastwood1, Courtney Pilcher1

  • 1STEM College, RMIT University, 225-245 Plenty Rd, Bundoora, VIC, 3083, Australia.

Cancer Metastasis Reviews
|November 23, 2024
PubMed

Insights

Kinesin-like protein 18A (KIF18A) is crucial for cancer cell survival and division, especially in tumors with chromosomal instability. Targeting KIF18A offers a promising therapeutic strategy for these cancers.

Area of Science:

  • Molecular biology
  • Cell biology
  • Oncology

Background:

  • Kinesin-like protein 18A (KIF18A) is a motor protein regulating microtubule dynamics and chromosome segregation.
  • Elevated KIF18A expression is linked to various cancers, suggesting a role in tumor progression.
  • KIF18A is essential for cancer cell proliferation but not normal somatic cell division.

Purpose of the Study:

  • To review the structural and functional characteristics of KIF18A.
  • To elucidate the role of KIF18A in cancer development and progression.
  • To evaluate therapeutic strategies targeting KIF18A for cancer treatment.

Main Methods:

  • Literature review of KIF18A's role in cell division and cancer.
  • Analysis of preclinical studies on KIF18A function in cancer cells.
  • Evaluation of current and emerging KIF18A-targeted cancer therapies.

Main Results:

  • KIF18A controls microtubule length, vital for cell division.
  • Cancer cells, particularly those with chromosomal instability, depend on KIF18A for survival.
  • KIF18A inhibition selectively impacts cancer cell division.

Conclusions:

  • KIF18A is a critical mediator of cancer cell division and survival.
  • The dependency of chromosomally unstable cancers on KIF18A makes it a viable therapeutic target.
  • Targeting KIF18A presents a promising avenue for novel cancer treatment strategies.
Keywords:
CancerChromosomal instabilityDrug targetKinesin-like protein KIF18A

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K